Publication | Closed Access

In vivo anti-tumor effect of PEG liposomal doxorubicin (DOX) in DOX-resistant tumor-bearing mice: Involvement of cytotoxic effect on vascular endothelial cells

Tumor BiologyOncologyDox-resistant Tumor-bearing MicePeg Liposomal DoxorubicinMedicineTumor TargetingAnti-cancer AgentVivo Anti-tumor EffectPharmacologyRadiation OncologyCancer Research